Filing Details
- Accession Number:
- 0001209191-24-001057
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-05 17:43:45
- Reporting Period:
- 2024-01-04
- Accepted Time:
- 2024-01-05 17:43:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1571949 | Intercontinental Exchange Inc. | ICE | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1343882 | C Jeffrey Sprecher | 5660 New Northside Drive Atlanta GA 30328 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-01-04 | 58,388 | $50.01 | 1,210,763 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-01-04 | 8,401 | $125.03 | 1,202,362 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-01-04 | 46,787 | $126.02 | 1,155,575 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-01-04 | 3,200 | $126.44 | 1,152,375 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-01-04 | 15,269 | $125.02 | 2,866,436 | No | 4 | S | Indirect | CPEX |
Common Stock | Disposition | 2024-01-04 | 82,150 | $125.99 | 2,784,286 | No | 4 | S | Indirect | CPEX |
Common Stock | Disposition | 2024-01-04 | 12,581 | $126.41 | 2,771,705 | No | 4 | S | Indirect | CPEX |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | CPEX |
No | 4 | S | Indirect | CPEX |
No | 4 | S | Indirect | CPEX |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) Holding | Disposition | 2024-01-04 | 58,388 | $0.00 | 58,388 | $50.01 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
116,777 | 2026-01-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 81,570 | Indirect | By spouse |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of August 7, 2023.
- Amount of securities beneficially owned includes 110 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 29, 2023.
- The price range for the aggregate amount sold by the direct holder is $124.41 - $125.39. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- The price range for the aggregate amount sold by the direct holder is $125.41 - $126.40. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- The price range for the aggregate amount sold by the direct holder is $126.41 - $126.50. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- The common stock number referred in Table I is an aggregate number and represents 1,110,990 shares of common stock and 41,385 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.
- The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
- The price range for the aggregate amount sold by the direct holder is $124.34 - $125.33. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- The price range for the aggregate amount sold by the direct holder is $125.34 - $126.33. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- The price range for the aggregate amount sold by the direct holder is $126.34 - $126.50. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- As previously reported, the reporting person also indirectly owns 2,771,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.
- As previously reported, the reporting person also indirectly owns 81,570 shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.
- These options are fully vested.